Loading...
XTSE
JWEL
Market cap919mUSD
Apr 11, Last price  
30.57CAD
1D
1.87%
1Q
-11.52%
IPO
74.69%
Name

Jamieson Wellness Inc

Chart & Performance

D1W1MN
P/E
24.56
P/S
1.74
EPS
1.24
Div Yield, %
1.93%
Shrs. gr., 5y
1.58%
Rev. gr., 5y
16.29%
Revenues
734m
+8.52%
193,218,000230,865,000248,331,000300,619,000319,776,000344,980,000403,661,000451,032,000547,369,000676,172,000733,780,000
Net income
52m
+8.42%
-33,176,000-95,382,000-25,166,000-23,787,00026,673,00031,657,00041,598,00052,082,00052,808,00047,882,00051,914,000
CFO
62m
+94.17%
9,847,00018,009,00029,009,00017,845,00027,805,00016,396,00040,596,00044,405,00050,589,00031,713,00061,578,000
Dividend
Aug 30, 20240.21 CAD/sh
Earnings
May 07, 2025

Profile

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells natural health products in Canada and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and Lorna Vanderhaeghe brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands. The Strategic Partners segment provides manufacturing and product development services on a contract manufacturing basis to blue-chip consumer health companies and retailers. Jamieson Wellness Inc. sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
URL
https://investors.jamiesonwellness.com
IPO date
Jul 07, 2017
Employees
891
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
733,780
8.52%
676,172
23.53%
547,369
21.36%
Cost of revenue
639,927
588,785
464,180
Unusual Expense (Income)
NOPBT
93,853
87,387
83,189
NOPBT Margin
12.79%
12.92%
15.20%
Operating Taxes
24,665
19,631
17,695
Tax Rate
26.28%
22.46%
21.27%
NOPAT
69,188
67,756
65,494
Net income
51,914
8.42%
47,882
-9.33%
52,808
1.39%
Dividends
(33,459)
(30,257)
(26,323)
Dividend yield
2.13%
2.24%
1.78%
Proceeds from repurchase of equity
(949)
(29,004)
BB yield
0.06%
2.14%
Debt
Debt current
7,546
4,852
Long-term debt
308,285
496,471
461,931
Deferred revenue
Other long-term liabilities
114,980
1,078
62,860
Net debt
263,498
467,154
(311,287)
Cash flow
Cash from operating activities
61,578
31,713
50,589
CAPEX
(9,181)
(8,835)
(14,570)
Cash from investing activities
(10,164)
(35,131)
(256,530)
Cash from financing activities
(45,434)
14,041
225,406
FCF
69,132
28,296
24,175
Balance
Cash
44,787
36,863
26,240
Long term investments
751,830
Excess cash
8,098
3,054
750,702
Stockholders' equity
509,840
447,401
414,476
Invested Capital
963,547
942,205
477,440
ROIC
7.26%
9.55%
19.68%
ROCE
9.06%
8.69%
8.76%
EV
Common stock shares outstanding
42,843
42,651
42,116
Price
36.71
15.69%
31.73
-9.58%
35.09
-12.58%
Market cap
1,572,774
16.22%
1,353,300
-8.43%
1,477,863
-11.67%
EV
1,879,471
1,862,716
1,166,576
EBITDA
112,385
107,710
100,437
EV/EBITDA
16.72
17.29
11.61
Interest
20,272
22,784
12,417
Interest/NOPBT
21.60%
26.07%
14.93%